Reprocessing: From FDA Regulation to Best Practice

Reprocessing: From FDA Regulation to Best Practice

AMDR is honored to be included in the April issue of DOTmed’s HealthCare Business news. AMDR is celebrating its 20th year and the article, written by Dan Vukelich (AMDR’s President and CEO), explores the path of single-use device (SUD) reprocessing, from FDA regulation to best practice.  Safety, savings and sustainability are cornerstones of the FDA-regulated reprocessing industry.  AMDR members are committed to assisting health systems to maximize economic and environmental benefits of reprocessing. The article also provides an overview of the reprocessing procedure, which medical devices are commonly reprocessed and provides an overview of the proven safety record of the industry. To maximize the savings and sustainability potential of reprocessing, hospitals can partner with multiple vendors (OEM and reprocessor) to maintain more clinical autonomy and control over their device mix. A fact sheet created by AMDR also explores how to best maximize SUD reprocessing savings. The full article from DOTmed’s Healthcare Business news can be found here.

By | 2017-09-06T17:09:43+00:00 April 4th, 2017|In the Press|0 Comments